Literature DB >> 9712890

The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage.

S C Kampranis1, A Maxwell.   

Abstract

Quinolone binding to the gyrase-DNA complex induces a conformational change that results in the blocking of supercoiling. Under these conditions gyrase is still capable of ATP hydrolysis which now proceeds through an alternative pathway involving two different conformations of the enzyme (Kampranis, S. C., and Maxwell, A. (1998) J. Biol. Chem. 269, 22606-22614). The kinetics of ATP hydrolysis via this pathway have been studied and found to differ from those of the reaction of the drug-free enzyme. The quinolone-characteristic ATPase rate is DNA-dependent and can be induced in the presence of DNA fragments as small as 20 base pairs. By observing the conversion of the ATPase rate to the quinolone characteristic rate, the formation and dissociation of the gyrase-DNA-quinolone complex can be monitored. Comparison of the time dependence of the conversion of the gyrase ATPase with that of DNA cleavage reveals that formation of the gyrase-DNA-quinolone complex does not correspond to the formation of cleaved DNA. Quinolone-induced DNA cleavage proceeds via a mechanism consisting of two cleavage events that is modulated in the presence of a nucleotide cofactor. We demonstrate that quinolone binding and drug-induced DNA cleavage are separate processes constituting two sequential steps in the mechanism of action of quinolones on DNA gyrase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712890     DOI: 10.1074/jbc.273.35.22615

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  A model for the mechanism of strand passage by DNA gyrase.

Authors:  S C Kampranis; A D Bates; A Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites.

Authors:  D B Zamble; D A Miller; J G Heddle; A Maxwell; C T Walsh; F Hollfelder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

Review 3.  Quinolone-mediated bacterial death.

Authors:  Karl Drlica; Muhammad Malik; Robert J Kerns; Xilin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

4.  A Roadblock-and-Kill Mechanism of Action Model for the DNA-Targeting Antibiotic Ciprofloxacin.

Authors:  Nikola Ojkic; Elin Lilja; Susana Direito; Angela Dawson; Rosalind J Allen; Bartlomiej Waclaw
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 5.  How antibiotics kill bacteria: from targets to networks.

Authors:  Michael A Kohanski; Daniel J Dwyer; James J Collins
Journal:  Nat Rev Microbiol       Date:  2010-05-04       Impact factor: 60.633

6.  A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases.

Authors:  Michael T Guarnieri; Brian S J Blagg; Rui Zhao
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

7.  Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase.

Authors:  Rupesh Kumar; Bhavani Shankar Madhumathi; Valakunja Nagaraja
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

8.  Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase.

Authors:  U H Manjunatha; M Dalal; M Chatterji; D R Radha; S S Visweswariah; V Nagaraja
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

9.  Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group.

Authors:  T Lu; X Zhao; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 10.  Topological Behavior of Plasmid DNA.

Authors:  N Patrick Higgins; Alexander V Vologodskii
Journal:  Microbiol Spectr       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.